Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nedaplatin vs Cisplatin with Radiotherapy for Locally Advanced HNSCC
NCT05039606Phase 2Not yet recruiting
- Sponsor
- Guizhou Medical University
- Start
- Sep 2021
- Primary completion
- Sep 2026
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of nedaplatin in head and neck squamous cell carcinoma (HNSCC), sponsored by Guizhou Medical University. Planned start Sep 2021; status: not yet recruiting.
02
Drugs
nedaplatin
03
Conditions
head and neck squamous cell carcinoma (HNSCC)
Beyond the preview
Go deeper on NCT05039606.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05039606.